208 related articles for article (PubMed ID: 16951355)
1. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein.
Chattopadhyay K; Bhatia S; Fiser A; Almo SC; Nathenson SG
J Immunol; 2006 Sep; 177(6):3920-9. PubMed ID: 16951355
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding sites of inducible costimulator and high avidity mutants with improved function.
Wang S; Zhu G; Tamada K; Chen L; Bajorath J
J Exp Med; 2002 Apr; 195(8):1033-41. PubMed ID: 11956294
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human inducible costimulator ligand expression and function.
Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules.
Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M
J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480
[TBL] [Abstract][Full Text] [Related]
5. LICOS, a primordial costimulatory ligand?
Brodie D; Collins AV; Iaboni A; Fennelly JA; Sparks LM; Xu XN; van der Merwe PA; Davis SJ
Curr Biol; 2000 Mar; 10(6):333-6. PubMed ID: 10744980
[TBL] [Abstract][Full Text] [Related]
6. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS
J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666
[TBL] [Abstract][Full Text] [Related]
7. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.
Wang S; Zhu G; Chapoval AI; Dong H; Tamada K; Ni J; Chen L
Blood; 2000 Oct; 96(8):2808-13. PubMed ID: 11023515
[TBL] [Abstract][Full Text] [Related]
8. Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis.
O'Dwyer R; Kovaleva M; Zhang J; Steven J; Cummins E; Luxenberg D; Darmanin-Sheehan A; Carvalho MF; Whitters M; Saunders K; Barelle CJ
J Immunol Res; 2018; 2018():4089459. PubMed ID: 30417018
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R
J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703
[TBL] [Abstract][Full Text] [Related]
11. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
[TBL] [Abstract][Full Text] [Related]
12. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
[TBL] [Abstract][Full Text] [Related]
14. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function.
Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y
J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237
[TBL] [Abstract][Full Text] [Related]
15. Identification of conserved amino acids in murine B7-1IgV domain critical for CTLA4/CD28:B7 interaction by site-directed mutagenesis: a novel structural model of the binding site.
Guo Y; Wu Y; Kong X; Liu Y
Mol Immunol; 1998 Mar; 35(4):215-25. PubMed ID: 9736337
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor.
Ling V; Wu PW; Finnerty HF; Bean KM; Spaulding V; Fouser LA; Leonard JP; Hunter SE; Zollner R; Thomas JL; Miyashiro JS; Jacobs KA; Collins M
J Immunol; 2000 Feb; 164(4):1653-7. PubMed ID: 10657606
[TBL] [Abstract][Full Text] [Related]
17. Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells.
Tang G; Qin Q; Zhang P; Wang G; Liu M; Ding Q; Qin Y; Shen Q
Cell Mol Life Sci; 2009 Sep; 66(18):3067-80. PubMed ID: 19603141
[TBL] [Abstract][Full Text] [Related]
18. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.
Watanabe R; Harada Y; Takeda K; Takahashi J; Ohnuki K; Ogawa S; Ohgai D; Kaibara N; Koiwai O; Tanabe K; Toma H; Sugamura K; Abe R
J Immunol; 2006 Jul; 177(2):1085-91. PubMed ID: 16818765
[TBL] [Abstract][Full Text] [Related]
19. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
20. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
